Matthew Longo is a Senior Research Associate at Vaxxinity since December 2021, specializing in quantitative biomarker development for pre-clinical and clinical settings. Key contributions include leading efforts in ELISA/MSD assays, developing cell profiling platforms, and validating tau ELISA kits, along with extensive experience in flow cytometry and data management. Prior roles include Research Associate positions at the University of Central Florida and Sanford Burnham Prebys Medical Discovery Institute, focusing on metabolic assays, bioinformatics, and in vivo and in vitro techniques for studying various diseases. Matthew Longo holds three Bachelor of Science degrees in Biotechnology, Molecular Biology, and Microbiology from the University of Central Florida.
This person is not in the org chart
This person is not in any teams
This person is not in any offices